Back
Cerevel Therapeutics Holdings Quote, Financials, Valuation and Earnings
![](/images/offers/ims/large/offer3.jpg)
Wall Street's Worst Nightmare: Small Town Trader's AI Edge
See the AI advantage for everyday Americans.
Buy
71
CERE
Cerevel Therapeutics Holdings
Last Price:
44.62
Seasonality Move:
12.94%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer4.jpg)
$1,300 into $45,000 in just 4 MONTHS?!
See here to see the full details.Cerevel Therapeutics Holdings Price Quote
$44.62
+0.23 (+0.52%)
(Updated: July 26, 2024 at 6:55 PM ET)
Cerevel Therapeutics Holdings Key Stats
Buy
71
Cerevel Therapeutics Holdings (CERE)
is a Buy
Day range:
$43.75 - $44.54
52-week range:
$19.59 - $44.54
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
14.33%
Volume:
6.8M
Avg. volume:
2.4M
1-year change:
44.45%
Market cap:
$8.1B
Revenue:
$0
EPS:
$-2.73
How Much Does Cerevel Therapeutics Holdings Make?
Data Unavailable
Is Cerevel Therapeutics Holdings Growing As A Company?
Data Unavailable
Cerevel Therapeutics Holdings Stock Price Performance
-
Did Cerevel Therapeutics Holdings Stock Go Up Last Month?
Cerevel Therapeutics Holdings share price went up by 12.21% last month -
Did CERE's Share Price Rise Over The Last Year?
CERE share price rose by 44.45% over the past 1 year
What Is Cerevel Therapeutics Holdings 52-Week High & Low?
-
What Is Cerevel Therapeutics Holdings’s 52-Week High Share Price?
Cerevel Therapeutics Holdings has traded as high as $44.54 over the past 52 weeks -
What Is Cerevel Therapeutics Holdings’s 52-Week Low Share Price?
Cerevel Therapeutics Holdings has traded as low as $19.59 over the past 52 weeks
Cerevel Therapeutics Holdings Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Cerevel Therapeutics Holdings?
-
How Much Debt Does Cerevel Therapeutics Holdings Have?
Total long term debt quarterly is $0 -
How Much Cash Does Cerevel Therapeutics Holdings Have?
Cash and short term investments quarterly total is $846.3M -
What Is Cerevel Therapeutics Holdings’s Book Value Per Share?
Book value per share is 3.10
Is Cerevel Therapeutics Holdings Cash Flow Positive?
-
What Is CERE Cash Flow From Operations?
Cash flow from operations (TTM) is -$367M -
What Is Cerevel Therapeutics Holdings’s Cash Flow From Financing?
Cash flow from financing (TTM) is $551.7M -
What Is Cerevel Therapeutics Holdings’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$17.9M
Cerevel Therapeutics Holdings Return On Invested Capital
Data Unavailable
Cerevel Therapeutics Holdings Earnings Date & Stock Price
-
What Is Cerevel Therapeutics Holdings's Stock Price Today?
A single share of CERE can be purchased today for 44.39 -
What Is Cerevel Therapeutics Holdings’s Stock Symbol?
Cerevel Therapeutics Holdings trades on the nasdaq under the ticker symbol: CERE -
When Is Cerevel Therapeutics Holdings’s Next Earnings Date?
The next quarterly earnings date for Cerevel Therapeutics Holdings is scheduled on August 2, 2024 -
When Is CERE's next ex-dividend date?
Cerevel Therapeutics Holdings's next ex-dividend date is July 26, 2024 -
How To Buy Cerevel Therapeutics Holdings Stock?
You can buy Cerevel Therapeutics Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Cerevel Therapeutics Holdings Competitors
-
Who Are Cerevel Therapeutics Holdings's Competitors?
Below is a list of companies who compete with Cerevel Therapeutics Holdings or are related in some way:
Cerevel Therapeutics Holdings Dividend Yield
Data Unavailable
Cerevel Therapeutics Holdings Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -48.98% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 7 |
Sell Recommendations: | 0 |
Price Target: | 45.00 |
Upside from Last Price: | 1.37% |